Morgan Dempsey Capital Management »

C4 Therapeutics shares owned by Morgan Dempsey Capital Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Morgan Dempsey Capital Management from 13F filings

Historical chart of Morgan Dempsey Capital Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Morgan Dempsey Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Morgan Dempsey Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.6k 1.5k 5.70

More positions owned by Morgan Dempsey Capital Management

Entergy Corporation Call Option (ETR)
Citigroup Com New (C)
At&t Call Option (T)
Exxon Mobil Corporation Call Option (XOM)
Cisco Systems (CSCO)
International Business Machines (IBM)
Wec Energy Group (WEC)
Cummins (CMI)
Lockheed Martin Corporation (LMT)
Philip Morris International (PM)
Chevron Corporation Call Option (CVX)
Prudential Financial Call Option (PRU)
Pembina Pipeline Corp Call Option (PBA)
Spdr Ser Trust -spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Coca-Cola Company (KO)

View all positions for Morgan Dempsey Capital Management

Top funds holding C4 Therapeutics

Soleus Capital Management
Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
OrbiMed Advisors
Morgan Stanley
Commodore Capital
Vanguard Group
Samlyn Capital
Bank of America Corporation
Adage Capital Partners GP
Geode Capital Management
Arrowpoint Asset Management
Silverarc Capital Management

View all funds holding C4 Therapeutics